RemeGen Co

RemeGen Co Net Margin

The Net Profit Margin of RemeGen Co (688331.SS) as of Oct 26, 2026 is 21.79 %. In the previous year, Net Profit Margin was -85.53 % — a change of -125.48% (higher).

Net Margin

21.79 %

YoY

-125.48%

Last updated:

Net Profit Margin of RemeGen Co is 2025 21.79 % . Net Profit Margin of RemeGen Co was 2024 -85.53 % . It decreases by -125.48% higher compared to the previous year.

For RemeGen Co, the net margin of 21.8% is up versus 19.4% a few years ago.

The RemeGen Co Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
-2,384.49 CNY
Jan 1, 2019
-16,047.44 CNY
Jan 1, 2020
143,673.26 CNY
Jan 1, 2021
19.40 CNY
Jan 1, 2022
-129.36 CNY
Jan 1, 2023
-139.55 CNY
Jan 1, 2024
-85.53 CNY
Jan 1, 2025
21.79 CNY
The RemeGen Co Net Margin history
YEARNet MarginYoY
21.79 %-125.48%
-85.53 %-38.71%
-139.55 %+7.87%
-129.36 %-766.77%
19.40 %-99.99%
143,673.26 %-995.30%
-16,047.44 %+572.99%
-2,384.49 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RemeGen Co Stock analysis

What does RemeGen Co do? RemeGen Co Ltd generates revenue by researching, developing, and manufacturing innovative biopharmaceuticals, specifically focusing on therapeutic antibody drugs. The company's product portfolio includes tetacept (RC18), veldicitumab (RC48), and a dual-target fusion protein (RC28). These products are designed to treat major diseases such as oncology, autoimmune diseases, and ophthalmology. The firm operates primarily in the domestic market within China, where it commercializes its discoveries. Its business model relies on the development of various antibody types, including antibody drug conjugates (ADCs), antibody fusion proteins, monoclonal antibodies, and bispecific antibodies. This focus allows the company to address significant medical needs through its specialized therapeutic offerings. RemeGen Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RemeGen Co stock

Net Profit Margin of RemeGen Co is 21.79 % in 2025.

Net Profit Margin of RemeGen Co changed from -85.53 % to 21.79 %, representing a -125.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin RemeGen Co since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's RemeGen Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — RemeGen Co

All Key Metrics — RemeGen Co